Drugs / Perfluorobutane
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05068076 | Oct → Dec 2021 | hepatocellular carcinoma | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Perfluorobutane | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05068076 ↗ |
| Modality | Diagnostic / imaging agent | “Kupffer phase ultrasound contrast agent (perfluorobutane)” NCT05068076 ↗ |